MedPath

CABOMETYX 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CABOMETYX 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1161136006

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Dec 5, 2016

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1161136006
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

CABOZANTINIBActive
Quantity: 76.03 mg
Name: CABOZANTINIB

ATC CLASSIFICATION (3)

L01E
L01EX
L01EX07

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.